791 related articles for article (PubMed ID: 7539890)
1. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
[TBL] [Abstract][Full Text] [Related]
3. Low-dose amiodarone in severe chronic heart failure.
Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
[TBL] [Abstract][Full Text] [Related]
4. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
[TBL] [Abstract][Full Text] [Related]
6. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
[TBL] [Abstract][Full Text] [Related]
11. Increased mortality after dronedarone therapy for severe heart failure.
Køber L; Torp-Pedersen C; McMurray JJ; Gøtzsche O; Lévy S; Crijns H; Amlie J; Carlsen J;
N Engl J Med; 2008 Jun; 358(25):2678-87. PubMed ID: 18565860
[TBL] [Abstract][Full Text] [Related]
12. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmias in heart failure--the role of amiodarone.
Dargie HJ; Cleland JG
Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II26-30. PubMed ID: 3271192
[TBL] [Abstract][Full Text] [Related]
14. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
[TBL] [Abstract][Full Text] [Related]
15. [Anti-arrhythmic therapy and cardiac failure].
Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
[TBL] [Abstract][Full Text] [Related]
16. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
[TBL] [Abstract][Full Text] [Related]
17. [What is the latest in anti-arrhythmia therapy?].
Gloor HO
Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmias and sudden death after dynamic cardiomyoplasty.
Bocchi EA; Moreira LF; de Moraes AV; Bacal F; Sosa E; Stolf NA; Bellotti G; Jatene AD; Pilleggi F
Circulation; 1994 Nov; 90(5 Pt 2):II107-11. PubMed ID: 7955235
[TBL] [Abstract][Full Text] [Related]
20. [Management of patients with risk of sudden death. The amiodarone example].
Djian J
Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
